While the classical IL-6 signaling pathway decreases the pro-inflammatory cytokines TNF-α and IL-1β, the trans-signaling pathway activates these pro-inflammatory pathways leading to chronical inflammation and tumor promotion [37]. The gene discussed is IL1B; the disease is neoplasm.